AnaptysBio, Inc. (ANAB) NASDAQ
64.81
+1.02(+1.60%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
64.81
+1.02(+1.60%)
Currency In USD
| Market Cap | 1.35B |
| Enterprise Value | 1.12B |
| P/E Ratio | -136.11 |
| PEG Ratio | -1.52 |
| Price/Sales Ratio | 7.94 |
| Price/Book Ratio | 48.4 |
| Enterprise/Revenue | 8.17 |
| Enterprise/EBITDA | 28.7 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | -0.06 |
| Operating Margin | 0.2 |
| Return On Assets | -0.04 |
| Return On Equity | 18.14 |
| Revenue | 234.6M |
| Revenue/Share | 8.44 |
| Gross Profit | 232.18M |
| EBITDA | 50.32M |
| Net Income | -13.23M |
| Diluted EPS | -0.46 |
| Total Cash | 311.64M |
| Total Cash/Share | 11.21 |
| Total Debt | 290.64M |
| Total Debt/Equity | 7.81 |
| Current Ratio | 9.07 |
| Book Value Per Share | 1.34 |
| 52-Week Change | 287.39 |
| 52-Week High | 66.66 |
| 52-Week Low | 15.32 |
| Moving Average 50 Days | 51.64 |
| Moving Average 200 Days | 35.12 |
| Average Volume | 490,188 |
| Shares Outstanding | 28.75M |
| % Held by Institutions | 101 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |